Table 2 Comparisons between Ratio_high group and Ratio_low group.
From: Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients
Ratio | High | Low | P |
|---|---|---|---|
N | 77 | 77 | Â |
Age (mean (SD)) | 60.30 (8.68) | 61.65 (9.16) | 0.349 |
Gender = MALE (%) | 53 (68.8) | 54 (70.1) | 1 |
Subtype = LUSC (%) | 9 (11.7) | 17 (22.1) | 0.132 |
ECOG (mean (SD)) | 0.95 (0.32) | 0.93 (0.27) | 0.721 |
Stage (mean (SD)) | 3.75 (0.59) | 3.81 (0.51) | 0.483 |
Response (%) | Â | Â | 0.157 |
PD | 17 (22.4) | 11 (14.3) | Â |
PR | 22 (28.9) | 33 (42.9) | Â |
SD | 37 (48.7) | 33 (42.9) | Â |
PFS/days (mean (SD)) | 139.59 (76.16) | 179.08 (83.75) | 0.003 |
Regimen (%) | Â | Â | 0.227 |
CT-only | 25 (32.5) | 20 (26.0) | Â |
CT + ICIs | 17 (22.1) | 24 (31.2) |  |
CT + TKIs | 5 (6.5) | 10 (13.0) |  |
CT + VEGFIs | 30 (39.0) | 23 (29.9) |  |
